Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease

被引:125
作者
Cummings, Damian M. [1 ]
Andre, Veronique M. [1 ]
Uzgil, Besim O. [1 ]
Gee, Steven M. [1 ]
Fisher, Yvette E. [1 ]
Cepeda, Carlos [1 ]
Levine, Michael S. [1 ]
机构
[1] Univ Calif Los Angeles, Mental Retardat Res Ctr, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
RECEPTOR-MEDIATED EXCITOTOXICITY; LONG-TERM POTENTIATION; STRIATAL NEURONAL LOSS; SYNAPTIC PLASTICITY; TRANSGENIC MICE; CORTICOSTRIATAL PATHWAY; MUTANT HUNTINGTIN; EARLY MOTOR; SENSITIVITY; EXPRESSION;
D O I
10.1523/JNEUROSCI.1592-09.2009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previously, we identified progressive alterations in spontaneous EPSCs and IPSCs in the striatum of the R6/2 mouse model of Huntington's disease (HD). Medium-sized spiny neurons from these mice displayed a lower frequency of EPSCs, and a population of cells exhibited an increased frequency of IPSCs beginning at similar to 40 d, a time point when the overt behavioral phenotype begins. The cortex provides the major excitatory drive to the striatum and is affected during disease progression. We examined spontaneous EPSCs and IPSCs of somatosensory cortical pyramidal neurons in layers II/III in slices from three different mouse models of HD: the R6/2, the YAC128, and the CAG140 knock-in. Results revealed that spontaneous EPSCs occurred at a higher frequency, and evoked EPSCs were larger in behaviorally phenotypic mice whereas spontaneous IPSCs were initially increased in frequency in all models and subsequently decreased in R6/2 mice after they displayed the typical R6/2 overt behavioral phenotype. Changes in miniature IPSCs and evoked IPSC paired-pulse ratios suggested altered probability of GABA release. Also, in R6/2 mice, blockade of GABA(A) receptors induced complex discharges in slices and seizures in vivo at all ages. In conclusion, altered excitatory and inhibitory inputs to pyramidal neurons in the cortex in HD appear to be a prevailing deficit throughout the development of the disease. Furthermore, the differences between synaptic phenotypes in cortex and striatum are important for the development of future therapeutic approaches, which may need to be targeted early in the development of the phenotype.
引用
收藏
页码:10371 / 10386
页数:16
相关论文
共 70 条
[11]   NMDA receptor function in mouse models of Huntington disease [J].
Cepeda, C ;
Ariano, MA ;
Calvert, CR ;
Flores-Hernández, J ;
Chandler, SH ;
Leavitt, BR ;
Hayden, MR ;
Levine, MS .
JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (04) :525-539
[12]   The corticostriatal pathway in Huntington's disease [J].
Cepeda, Carlos ;
Wu, Nanping ;
Andre, Veronique M. ;
Cummings, Damian M. ;
Levine, Michael S. .
PROGRESS IN NEUROBIOLOGY, 2007, 81 (5-6) :253-271
[13]   Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses [J].
Choi, S ;
Lovinger, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2665-2670
[14]   A COMPARISON OF PAIRED-PULSE FACILITATION OF AMPA AND NMDA RECEPTOR-MEDIATED EXCITATORY POSTSYNAPTIC CURRENTS IN THE HIPPOCAMPUS [J].
CLARK, KA ;
RANDALL, AD ;
COLLINGRIDGE, GL .
EXPERIMENTAL BRAIN RESEARCH, 1994, 101 (02) :272-278
[15]  
Cummings D.M., 2008, Soc. Neurosci. Abstr, V34, p433.411
[16]   Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease [J].
Cummings, Damian M. ;
Milnerwood, Austen J. ;
Dallerac, Glenn M. ;
Vatsavayai, Sarat C. ;
Hirst, Mark C. ;
Murphy, Kerry P. S. J. .
BRAIN RESEARCH BULLETIN, 2007, 72 (2-3) :103-107
[17]   Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease [J].
Cummings, Damian M. ;
Milnerwood, Austen J. ;
Dallerac, Glenn M. ;
Waights, Verina ;
Brown, Jacki Y. ;
Vatsavayai, Sarat C. ;
Hirst, Mark C. ;
Murphy, Kerry P. S. J. .
HUMAN MOLECULAR GENETICS, 2006, 15 (19) :2856-2868
[18]   SELECTIVE SPARING OF A CLASS OF STRIATAL NEURONS IN HUNTINGTONS-DISEASE [J].
FERRANTE, RJ ;
KOWALL, NW ;
BEAL, MF ;
RICHARDSON, EP ;
BIRD, ED ;
MARTIN, JB .
SCIENCE, 1985, 230 (4725) :561-563
[19]   Juvenile Huntington's disease presenting as progressive myoclonic epilepsy [J].
Gambardella, A ;
Muglia, M ;
Labate, A ;
Magariello, A ;
Gabriele, AL ;
Mazzei, R ;
Pirritano, D ;
Conforti, FL ;
Patitucci, A ;
Valentino, P ;
Zappia, M ;
Quattrone, A .
NEUROLOGY, 2001, 57 (04) :708-711
[20]  
GARTHWAITE J, 1994, NMDA RECEPTOR, P428